Cargando…

Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a complication beyond the first-year post-heart transplantation (HTx). We aimed to test the utility of cardiac magnetic resonance (CMR) to detect functional/structural changes in HTx recipients with CAV. METHODS: Seventy-seven prospectively recruit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbasi, Muhannad A., Blake, Allison M., Sarnari, Roberto, Lee, Daniel, Anderson, Allen S., Ghafourian, Kambiz, Khan, Sadiya S., Vorovich, Esther E., Rich, Jonathan D., Wilcox, Jane E., Yancy, Clyde W., Carr, James C., Markl, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Echocardiography 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592247/ https://www.ncbi.nlm.nih.gov/pubmed/36280267 http://dx.doi.org/10.4250/jcvi.2022.0003

Ejemplares similares

Multiparametric Cardiac Magnetic Resonance Imaging for Diagnosing Cardiac Allograft Vasculopathy
por: Lee, Ji Won
Publicado: (2022)

Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
por: Miller, Christopher A, et al.
Publicado: (2014)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Shock – Classification and Pathophysiological Principles of Therapeutics
por: Kislitsina, Olga N., et al.
Publicado: (2019)

Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?
por: van den Hoogen, Patricia, et al.
Publicado: (2015)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients
por: Labarrere, Carlos A., et al.
Publicado: (2014)

Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19
por: Parikh, Neil U., et al.
Publicado: (2023)

Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013)

The novel proteomic signature for cardiac allograft vasculopathy
por: Wei, Dongmei, et al.
Publicado: (2022)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
por: Kobashigawa, Jon
Publicado: (2000)

Correction to: Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Ellimuttil, Tracey M, et al.
Publicado: (2021)

Allograft or Recipient ST2 Deficiency Oppositely Affected Cardiac Allograft Vasculopathy via Differentially Altering Immune Cells Infiltration
por: Zhang, Zhenggang, et al.
Publicado: (2021)

Relationship between cardiac allograft vasculopathy and left ventricular diastolic dysfunction assessed by cardiac magnetic resonance imaging in heart transplant recipients
por: Machida, Haruhiko, et al.
Publicado: (2009)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
por: Nair, Nandini
Publicado: (2022)

Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
por: Roest, Stefan, et al.
Publicado: (2022)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients
por: Johansson, Inger, et al.
Publicado: (2015)

Pharmacological vs Exercise Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy
por: Gebska, Milena A., et al.
Publicado: (2020)

Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy
por: Foldyna, Borek, et al.
Publicado: (2020)

Qualitative Perfusion Cardiac Magnetic Resonance Imaging Lacks Sensitivity in Detecting Cardiac Allograft Vasculopathy
por: Colvin-Adams, Monica, et al.
Publicado: (2011)

Diagnosis of chronic allograft vasculopathy using semiquantitative stress perfusion CMR in heart transplant patients
por: Schwid, Madeline, et al.
Publicado: (2016)

Association of CD14(+) monocyte-derived progenitor cells with cardiac allograft vasculopathy
por: Salama, Mohamed, et al.
Publicado: (2011)

Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab
por: Wang, Ricardo, et al.
Publicado: (2015)

Association of Intimal Neovessels Noted by Optical Coherence Tomography with Cardiac Allograft Vasculopathy
por: Chahal, Diljon S, et al.
Publicado: (2020)

Cardiac allograft vasculopathy diagnosed by vasodilator myocardial contrast echocardiography perfusion imaging
por: Prasad, Pooja, et al.
Publicado: (2023)

T(mem) time: Memory T-Cells in Cardiac Allograft Vasculopathy: Editorial to: “Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody” by Hao Wang et al.
por: Seidman, Michael A.
Publicado: (2014)

Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts
por: Gocht, Annika, et al.
Publicado: (2018)

Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography
por: Zanchin, Christian, et al.
Publicado: (2018)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019)

The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy
por: Dyrbuś, Maciej, et al.
Publicado: (2020)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy
por: Husain, Nazia, et al.
Publicado: (2021)

Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation
por: Roest, Stefan, et al.
Publicado: (2022)

Multiple Micro-Neo-Vessels Detected by Optical Coherence Tomography (OCT) May Predict a Progression of Cardiac Allograft Vasculopathy in Posttransplant Recipients
por: Suzuki, Toshiaki, et al.
Publicado: (2022)

The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences
por: Sciaccaluga, C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3cmtusaq51c8hj8fccih70dsgq